Taysha Gene Therapies, Inc.宣布,美国食品药品监督管理局(FDA)授予其突破性疗法认定,并就Tsha-102治疗Rett综合征项目提供了积极的监管进展更新。
Taysha Gene Therapies, Inc.宣布,美国食品药品监督管理局(FDA)授予其突破性疗法认定,并就Tsha-102治疗Rett综合征项目提供了积极的监管进展更新。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.